Last updated on March 2018

A clinical trial seeking patients for a research study of Semaglutide, Placebo

Brief description of study

Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis

Clinical Study Identifier: NCT02970942

Contact Investigators or Research Sites near you

Start Over

Novo Nordisk

Novo Nordisk Investigational Site
Penza, Russian Federation
  Connect »